The objective is to produce new imaging probes and associated protocols for preclinical biomedical research and for clinical use in humans. The first specific aim is to discover small synthetic molecules that selectively target anionic cell membrane surfaces with exposed phosphatidylserine and distinguish them from the near-neutral membrane surfaces of healthy cells. One application is cell death imaging, as a method to detect disease and measure treatment efficacy. Preliminary work has shown that a family of fluorescent zinc coordination complexes can act as optical imaging probes for dead and dying tissue in various cell and animal models. The selectivity over healthy tissue is very high, even though binding affinities for exposed phosphatidylserine are moderate (low micromolar dissociation constants). To improve cell targeting performance for clinical applications, a systematic cycle of synthesis and screening will be employed to find next-generation compounds that have 500-fold higher binding affinity for phosphatidylserine. This will enable microdosing, which is the key to successful translation. The imaging ability of lead compounds will be evaluated in cell culture and animal models of cell death with a focus on producing the first set of practically useful, optical imaging probes for non-invasive assessment of the efficacy of anticancer therapies. The second specific aim is to create a new paradigm for planar optical imaging of tumors using near-infrared chemiluminescent and fluorescent (CLF) nanoparticles. The chemiluminescence is thermally-activated (that is, no chemical or electrical stimulus is needed) which means that the nanoparticles can be stored at low temperature and they only become chemiluminescent when warmed to body temperature. Preliminary results in mice show that chemiluminescence imaging permits identification of target sites that are more than two centimeters below the animal surface, which is about five times deeper than currently achieved using planar fluorescence imaging. The new imaging paradigm will be demonstrated by conducting experiments using relatively deep-tissue animal models of spontaneous prostate cancer and orthotopic colon cancer. Chemiluminescence imaging will be used to locate the tumor tissue that is targeted by the nanoparticles, and fluorescence microscopy of thin histology sections taken from the same specimen will quantify uptake into the tumor parenchyma. The power of this new imaging technology will be employed to answer questions concerning the ability of the tumor vascular-penetrating peptide iRGD to promote nanoparticle entry into tumors.

Public Health Relevance

High performance imaging probes for cell death will facilitate the diagnosis and treatment of disease in diverse medical fields such as oncology, cardiology, organ transplantation, neurology, ophthalmology, and autoimmune disease. New chemiluminescent and fluorescent probes for planar optical imaging will accelerate efforts to develop effective tumor imaging and treatment methods.

National Institute of Health (NIH)
National Institute of General Medical Sciences (NIGMS)
Research Project (R01)
Project #
Application #
Study Section
Synthetic and Biological Chemistry A Study Section (SBCA)
Program Officer
Chin, Jean
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Notre Dame
Schools of Arts and Sciences
Notre Dame
United States
Zip Code
Plaunt, Adam J; Harmatys, Kara M; Hendrie, Kyle A et al. (2014) Chemically triggered release of 5-aminolevulinic acid from liposomes. RSC Adv 4:57983-57990
Plaunt, Adam J; Harmatys, Kara M; Wolter, William R et al. (2014) Library synthesis, screening, and discovery of modified Zinc(II)-Bis(dipicolylamine) probe for enhanced molecular imaging of cell death. Bioconjug Chem 25:724-37
Turkyilmaz, Serhan; Rice, Douglas R; Palumbo, Rachael et al. (2014) Selective recognition of anionic cell membranes using targeted liposomes coated with zinc(ii)-bis(dipicolylamine) affinity units. Org Biomol Chem 12:5645-55
Plaunt, Adam J; Clear, Kasey J; Smith, Bradley D (2014) ยน?F NMR indicator displacement assay using a synthetic receptor with appended paramagnetic relaxation agent. Chem Commun (Camb) 50:10499-501
Harmatys, Kara M; Cole, Erin L; Smith, Bradley D (2013) In vivo imaging of bone using a deep-red fluorescent molecular probe bearing multiple iminodiacetate groups. Mol Pharm 10:4263-71
Xiao, Shuzhang; Abu-Esba, Lica; Turkyilmaz, Serhan et al. (2013) Multivalent dendritic molecules as broad spectrum bacteria agglutination agents. Theranostics 3:658-66
Clear, Kasey J; Stroud, Sarah; Smith, Bradley D (2013) Dual colorimetric and luminescent assay for dipicolinate, a biomarker of bacterial spores. Analyst 138:7079-82
Smith, Bryan A; Harmatys, Kara M; Xiao, Shuzhang et al. (2013) Enhanced Cell Death Imaging Using Multivalent Zinc(II)-bis(dipicolylamine) Fluorescent Probes. Mol Pharm :
Gan, Haiying; Oliver, Allen G; Smith, Bradley D (2013) Fluorine NMR reporter for phosphate anions. Chem Commun (Camb) 49:5070-2
Lee, Jung-Jae; White, Alexander G; Rice, Douglas R et al. (2013) In vivo imaging using polymeric nanoparticles stained with near-infrared chemiluminescent and fluorescent squaraine catenane endoperoxide. Chem Commun (Camb) 49:3016-8

Showing the most recent 10 out of 49 publications